14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.27 $7.87 Wednesday, 24th Apr 2024 ARDX stock ended at $6.43. This is 0.626% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.31% from a day low at $6.39 to a day high of $6.66.
90 days $6.27 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Oct 24, 2023 $3.44 $3.80 $3.44 $3.78 5 996 409
Oct 23, 2023 $3.52 $3.56 $3.40 $3.46 5 793 749
Oct 20, 2023 $3.62 $3.80 $3.52 $3.56 6 146 613
Oct 19, 2023 $3.83 $3.90 $3.48 $3.64 14 369 730
Oct 18, 2023 $3.92 $4.12 $3.63 $3.91 58 292 223
Oct 17, 2023 $3.53 $3.74 $3.38 $3.45 6 887 195
Oct 16, 2023 $3.40 $3.63 $3.33 $3.47 6 117 658
Oct 13, 2023 $3.36 $3.37 $3.16 $3.33 6 839 994
Oct 12, 2023 $3.69 $3.70 $3.23 $3.29 7 761 868
Oct 11, 2023 $4.16 $4.20 $3.41 $3.54 11 696 772
Oct 10, 2023 $3.95 $4.23 $3.93 $4.14 5 511 330
Oct 09, 2023 $3.97 $3.97 $3.84 $3.96 3 249 608
Oct 06, 2023 $3.96 $4.03 $3.89 $3.97 3 570 647
Oct 05, 2023 $4.05 $4.11 $3.89 $4.04 5 657 909
Oct 04, 2023 $4.00 $4.05 $3.91 $4.04 2 731 037
Oct 03, 2023 $4.03 $4.07 $3.84 $3.99 4 144 343
Oct 02, 2023 $4.04 $4.24 $3.98 $4.06 4 448 123
Sep 29, 2023 $4.07 $4.12 $3.97 $4.08 4 708 556
Sep 28, 2023 $4.15 $4.19 $3.99 $4.04 3 239 698
Sep 27, 2023 $4.10 $4.19 $4.00 $4.14 3 855 950
Sep 26, 2023 $3.86 $4.27 $3.84 $4.06 5 010 089
Sep 25, 2023 $4.02 $4.00 $3.81 $3.89 6 692 200
Sep 22, 2023 $3.84 $4.00 $3.62 $3.95 8 216 570
Sep 21, 2023 $3.83 $3.85 $3.62 $3.66 4 943 126
Sep 20, 2023 $4.02 $4.05 $3.85 $3.86 4 209 589
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT